Mammalian ABC transporters in health and disease

P Borst, RO Elferink - Annual review of biochemistry, 2002 - annualreviews.org
▪ Abstract The ATP-binding cassette (ABC) transporters are a family of large proteins in
membranes and are able to transport a variety of compounds through membranes against …

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

CH Choi - Cancer cell international, 2005 - Springer
One of the major problems related with anticancer chemotherapy is resistance against
anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter …

Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition

KM Hanssen, M Haber, JI Fletcher - Drug Resistance Updates, 2021 - Elsevier
Resistance to chemotherapy remains one of the most significant obstacles to successful
cancer treatment. While inhibiting drug efflux mediated by ATP-binding cassette (ABC) …

Applications of catalytic asymmetric sulfide oxidations to the syntheses of biologically active sulfoxides

J Legros, JR Dehli, C Bolm - Advanced Synthesis & Catalysis, 2005 - Wiley Online Library
Optically active sulfoxides are important compounds for medicinal and pharmaceutical
chemistry. Driven by the increasing demand for efficient, selective and environmentally …

Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development

SF Zhou, LL Wang, YM Di, CC Xue… - Current medicinal …, 2008 - ingentaconnect.com
Human contains 49 ATP-binding cassette (ABC) transporter genes and the multidrug
resistance associated proteins (MRP1/ABCC1, MRP2/ABCC2, MRP3/ABCC3 …

Glial and myeloid heterogeneity in the brain tumour microenvironment

BM Andersen, C Faust Akl, MA Wheeler… - Nature Reviews …, 2021 - nature.com
Brain cancers carry bleak prognoses, with therapeutic advances hel** only a minority of
patients over the past decade. The brain tumour microenvironment (TME) is highly …

Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents

TR Steel, F Walsh, A Wieczorek-Błauż, M Hanif… - Coordination chemistry …, 2021 - Elsevier
Metallodrugs have a central role in the treatment and diagnosis of diseases. To overcome
potential toxicity and equip metal-based anticancer agents with biological activity, the choice …

Quinolones and non-steroidal anti-inflammatory drugs interacting with copper (II), nickel (II), cobalt (II) and zinc (II): structural features, biological evaluation and …

G Psomas, DP Kessissoglou - Dalton transactions, 2013 - pubs.rsc.org
The structural features of copper (II), nickel (II), cobalt (II) and zinc (II) complexes with the
antimicrobial drugs quinolones and non-steroidal anti-inflammatory drugs (NSAIDs) as …

Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy

MY Yang, RR Zhao, YF Fang, JL Jiang, XT Yuan… - International journal of …, 2019 - Elsevier
Nanoformulations with advantages in drug delivery, safety and pharmacodynamics have
been booming as a promising strategy for cancer therapy. However, the traditional …

Interaction of copper (II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: Synthesis, structure, DNA-and albumin-binding

F Dimiza, F Perdih, V Tangoulis, I Turel… - Journal of inorganic …, 2011 - Elsevier
Copper (II) complexes with the non-steroidal anti-inflammatory drugs (NSAIDs) naproxen
and diclofenac have been synthesized and characterized in the presence of nitrogen donor …